[1]Department of Pharmaceutical Sciences;
University of Tennessee Health Science Center;
Memphis;
TN;
38163;
USA;
[1]Department of Pharmaceutical Sciences;
University of Tennessee Health Science Center;
Memphis;
TN;
38163;
USA;
[1]Department of Pharmaceutical Sciences;
University of Tennessee Health Science Center;
Memphis;
TN;
38163;
USA;
[2]Department of Pharmaceutical Sciences;
College of Pharmacy and Health Sciences;
St.John’s University;
Queens;
NY 11439;
USA;
[1]Department of Pharmaceutical Sciences;
University of Tennessee Health Science Center;
Memphis;
TN;
38163;
USA;
[2]Department of Pharmaceutical Sciences;
College of Pharmacy and Health Sciences;
St.John’s University;
Queens;
NY 11439;
USA;
[1]Department of Pharmaceutical Sciences;
University of Tennessee Health Science Center;
Memphis;
TN;
38163;
USA;
selective survivin inhibitors; structure activity relationships; melanoma; human epidermoid carcinoma; colorectal cancer; P-glycoprotein drug efflux pumps;